… Ragheb Assaly … Ragheb Assaly … Ragheb Assaly: study design and conception,
critical revision of the manuscript. The authors read and approved the final manuscript …

The efficacy of tocilizumab (TOC), monoclonal antibody against interleukin‐6 (IL‐6) receptor,
in patients with coronavirus disease‐2019 (COVID‐19) patients has led to conflicting results…

Background and aims Micronutrient supplements such as vitamin D, vitamin C, and zinc
have been used in managing viral illnesses. However, the clinical significance of these …

To the Editor, We read with interest the study by Luo et al 1 that evaluates the efficacy of
tocilizumab (antibody against interleukin‐6 [IL‐6]) in patients with coronavirus disease 2019 (…

Background— Increased permeability, predominantly controlled by endothelial junction
stability, is an early event in the deterioration of vascular integrity in ischemic disorders. …

… cardiomyocyte death after I/R, both in vitro and in vivo. To better understand how TRO40303
provides protection against oxidative damage associated with I/R injury, we investigated its …

Morphine has been shown to protect the myocardium against ischemia-reperfusion injury
through inhibition of glycogen synthase kinase-3β (GSK-3β). Given that GSK-3β is known to …

Insulin resistance (IR), which can be assessed by triglyceride-glucose (TyG) index, is a major
contributor to the pathogenesis of cardiovascular diseases. Arterial stiffness is an index of …

Introduction: Multiple risk factors of mortality have been identified in patients with COVID-19.
Here, we sought to determine the effect of a history of neurological disorder and …

Background Systemic capillary leak syndrome (SCLS) is a rare disorder of unknown etiology
that is characterized by acute recurrent attacks of hypovolemic shock commonly following …